Clinical trial · Observational
Study Evaluating Renal Cell Carcinoma Risk Factors
Prospective, Multicenter, Epidemiological Study To Determine The Clinical, Molecular And Genetic Factors Associated To The Prognosis Of Patients With Advanced Renal Cell Carcinoma
NCT00927043CI-TRIAL-00005735MICRAcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is an epidemiological, prospective, multicenter study designed to identify the pre-treatment clinical, molecular and genetic prognostic factors associated with progression free survival in patients naïve to renal cell carcinoma (RCC) treatment.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Carcinoma, Renal Cell | Renal Cell Carcinoma | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Epidemiological study according to clinical practice | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- 1
- interventionNames
- Other: Epidemiological study according to clinical practice
Primary outcomes (1)
- measure
- Progression-free survival
- timeFrame
- 12 months
Secondary outcomes (2)
- measure
- Response rate.
- timeFrame
- 12 months
- measure
- Overall survival.
- timeFrame
- 12 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Treatment naïve patients with proven advanced RCC will be evaluated. (Except surgery or radiotherapy) * =18 years, any gender. * Patients with advanced Renal Cell Carcinoma and treatment naïve. Exclusion Criteria: * Patients who have already initiated any kind of specific therapy for the treatment of RCC.2. * Patients with other neoplasias different from RCC (current or past).
References
Publications (0)
Data not yet available
No reference posted for this study.